标题
Double hit and double expressors in lymphoma: Definition and treatment
作者
关键词
-
出版物
CANCER
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-09-26
DOI
10.1002/cncr.31646
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Outcomes after Allogeneic Stem Cell Transplantation in Patients with Double-Hit and Double-Expressor Lymphoma
- (2018) Alex F. Herrera et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation
- (2017) Alex F. Herrera et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission
- (2017) Daniel J. Landsburg et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non–Germinal Center B-Cell–Like Diffuse Large B-Cell Lymphoma
- (2017) John P. Leonard et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma
- (2017) Andy I. Chen et al. LEUKEMIA & LYMPHOMA
- Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma
- (2017) Andrés E Quesada et al. MODERN PATHOLOGY
- Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
- (2017) Stephen J. Schuster et al. NEW ENGLAND JOURNAL OF MEDICINE
- Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
- (2017) Sattva S. Neelapu et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular Aspects
- (2017) Lynh Nguyen et al. Genes
- Impact of dual expression of MYC and BCL2 by immunohistochemistry on the risk of CNS relapse in DLBCL
- (2016) K. J. Savage et al. BLOOD
- The 2016 revision of the World Health Organization classification of lymphoid neoplasms
- (2016) S. H. Swerdlow et al. BLOOD
- Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704
- (2016) Soham D. Puvvada et al. BRITISH JOURNAL OF HAEMATOLOGY
- Sole rearrangement but not amplification ofMYCis associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable
- (2016) Daniel J. Landsburg et al. BRITISH JOURNAL OF HAEMATOLOGY
- P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma
- (2016) Xuan J Wang et al. MODERN PATHOLOGY
- Diffuse Large B-cell Lymphomas of Immunoblastic Type Are a Major Reservoir for MYC-IGH Translocations
- (2015) Heike Horn et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA study
- (2015) C. Copie-Bergman et al. BLOOD
- Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis
- (2015) Christina Howlett et al. BRITISH JOURNAL OF HAEMATOLOGY
- Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma
- (2015) Daniel J. Landsburg et al. CANCER
- MYC Alterations in Diffuse Large B-Cell Lymphomas
- (2015) Kennosuke Karube et al. SEMINARS IN HEMATOLOGY
- MYC or BCL2 copy number aberration is a strong predictor of outcome in patients with diffuse large B-cell lymphoma
- (2015) Ting-Xun Lu et al. Oncotarget
- Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis
- (2014) A. M. Petrich et al. BLOOD
- ‘Double-Hit’ cytogenetic status may not be predicted by baseline clinicopathological characteristics and is highly associated with overall survival in B cell lymphoma patients
- (2014) Daniel J. Landsburg et al. BRITISH JOURNAL OF HAEMATOLOGY
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience
- (2014) Yasuhiro Oki et al. BRITISH JOURNAL OF HAEMATOLOGY
- TP53mutations are frequent events in double-hit B-cell lymphomas withMYCandBCL2but notMYCandBCL6translocations
- (2014) Niklas Gebauer et al. LEUKEMIA & LYMPHOMA
- Targeting BCL2 for the Treatment of Lymphoid Malignancies
- (2014) Mary Ann Anderson et al. SEMINARS IN HEMATOLOGY
- MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma
- (2013) H. Horn et al. BLOOD
- Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma
- (2013) S. M. Aukema et al. HAEMATOLOGICA
- MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy
- (2013) A. Valera et al. HAEMATOLOGICA
- MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation
- (2012) W. Cuccuini et al. BLOOD
- Double-hit BCL2/MYC translocations in a consecutive cohort of patients with large B-cell lymphoma - a single centre's experience
- (2012) Mette Ø. Pedersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Roles of BCL6 in normal and transformed germinal center B cells
- (2012) Katia Basso et al. IMMUNOLOGICAL REVIEWS
- Immunohistochemical Double-Hit Score Is a Strong Predictor of Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Tina Marie Green et al. JOURNAL OF CLINICAL ONCOLOGY
- Concurrent Expression of MYC and BCL2 in Diffuse Large B-Cell Lymphoma Treated With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone
- (2012) Nathalie A. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Gains of MYC locus and outcome in patients with diffuse large B-cell lymphoma treated with R-CHOP
- (2011) Monica Testoni et al. BRITISH JOURNAL OF HAEMATOLOGY
- Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial
- (2011) Frédéric Peyrade et al. LANCET ONCOLOGY
- BCL2 mutations in diffuse large B-cell lymphoma
- (2011) J M Schuetz et al. LEUKEMIA
- Intravenous methotrexate as central nervous system (CNS) prophylaxis is associated with a low risk of CNS recurrence in high-risk patients with diffuse large B-cell lymphoma
- (2010) Jeremy S. Abramson et al. CANCER
- Increased MYC gene copy number correlates with increased mRNA levels in diffuse large B-cell lymphoma
- (2010) C. J. Stasik et al. HAEMATOLOGICA
- Rearrangement ofMYCIs Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab
- (2010) Sharon Barrans et al. JOURNAL OF CLINICAL ONCOLOGY
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Aggressive Lymphomas
- (2010) Georg Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival
- (2009) N. A. Johnson et al. BLOOD
- MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy
- (2009) K. J. Savage et al. BLOOD
- Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations
- (2009) N. Tomita et al. HAEMATOLOGICA
- MYCtranslocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
- (2008) S O Yoon et al. HISTOPATHOLOGY
- Structural aberrations affecting the MYC locus indicate a poor prognosis independent of clinical risk factors in diffuse large B-cell lymphomas treated within randomized trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
- (2008) W Klapper et al. LEUKEMIA
- Apoptotic signaling by c-MYC
- (2008) B Hoffman et al. ONCOGENE
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation